• GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19

    18 days ago - By Fierce Biotech

    GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19 badams
    Wed, 02/17/2021 - 04:03
    Read more ...

     

  • Sanofi invests in health tech firm Novadiscovery, boosting trial simulation platform and COVID-19 work

    18 days ago - By Fierce Biotech

    Sanofi invests in health tech firm Novadiscovery, boosting trial simulation platform and COVID-19 work badams
    Wed, 02/17/2021 - 05:16
    Read more ...